17‐Beta‐Estradiol induces transformation and tumorigenesis in human breast epithelial cells

10.1016/S0140-6736(01)72307-0

10.1136/bmj.2.2077.1161

Block G., 1958, Estrogen excretion following operative and irradiation castration in cases of mammary cancer, Surgery, 43, 415

10.1073/pnas.57.6.1740

10.1016/0022-4731(86)90035-X

Dorgan J. F., 1996, Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk, Cancer Epidemiol. Biomarkers Prev., 5, 533

Dorgan J. F., 1997, Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstate-3β, 17β-diol to risk of breast cancer in postmenopausal women, Cancer Epidemiol. Biomarkers Prev., 6, 177

10.1038/bjc.1997.398

10.1093/jnci/90.17.1292

10.1093/jnci/87.3.190

10.1093/jnci/88.5.291

10.1093/oxfordjournals.aje.a116228

Kabuto M., 2000, A prospective study of estradiol and breast cancer in Japanese women, Cancer Epidemiol. Biomarkers Prev., 9, 575

10.7326/0003-4819-130-4_Part_1-199902160-00004

Helzlsouer K. J., 1994, Aprospective study of endogenous hormones and breast cancer, Cancer Detect. Prev., 18, 79

10.1093/jnci/94.8.606

Henderson B. E., 1988, Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture, Cancer Res., 48, 246

10.1093/oxfordjournals.epirev.a036102

10.1093/oxfordjournals.epirev.a036115

10.1093/oxfordjournals.epirev.a036116

10.1023/A:1006186719322

Russo I. H., 2005, MolecularBasis of Breast CancerPrevention and Treatment, 89

10.1016/0039-128X(87)90037-7

Russo J., 2000, Endocrine Disrupters of the Environment, 1

Li J. J., 1983, Relative carcinogenic activity of various synthetic and natural estrogens in the Syrian hamster kidney, Cancer Res., 43, 5200

Li J. J., 1995, Carcinogenic activities of various steroidal and nonsteroidal estrogens in the hamster kidney: Relation to hormonal activity and cell proliferation, Cancer Res., 55, 4347

10.1093/oxfordjournals.jncimonographs.a024245

10.1289/ehp.96104938

Meites J., 1972, Relation of prolactin and estrogen to mammary tumorigenesis in the rat, J. Natl. Cancer Inst., 48, 1217

10.1023/A:1026339111278

Bocchinfuso W. P., 1999, A mouse mammary tumor virus-Wnt1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha, Cancer Res., 59, 1869

10.1021/tx010042g

10.1093/carcin/bgg004

10.1073/pnas.94.20.10937

10.1016/0022-4731(86)90080-4

Li J. J., 1987, Estrogen carcinogenesis in Syrian hamster tissue: Role of metabolism, Federation Proc., 46, 1858

Newbold R. R., 2000, Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens, CancerRes., 60, 235

10.1038/sj.onc.1204969

10.1016/S0960-0760(01)00183-2

10.1016/S0960-0760(03)00390-X

Lareef M. H., 2005, The estrogen antagonist ICI-182,780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells, Int. J. Oncol., 26, 423

Fernandez S. V., 2005, Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites, Int. J. Oncol., 26, 691

10.1016/S0076-6879(04)82017-2

10.1111/j.1600-0463.2001.tb00013.x

10.1093/carcin/14.3.483

Calaf G., 1995, C-Ha-ras enhances the neoplastic transformation of human breast epithelial cells treated with chemical carcinogens, Int. J. Oncol., 6, 5

Forozan F., 2000, Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data, Cancer Res., 60, 4519

Russo J., 2005, Estrogens as carcinogens in the human breast, Proc. Am. Assoc. Cancer Res., 46, SY14-1

10.1111/j.1075-122X.2004.21410.x

10.1016/j.mrfmmm.2004.02.005

10.1002/ijc.21590

10.1002/mc.20125

10.1007/s00432-002-0407-5

10.1016/S0002-9440(10)64388-X

10.1016/S0165-4608(98)00217-9

10.1074/jbc.M204244200

10.1016/S0002-9440(10)63742-X

10.1023/A:1011043412634

10.1016/S0165-4608(99)00178-8

10.1210/jc.81.10.3663

Johannsdottir H. K., 2004, Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables, Anticancer Res., 24, 2681

10.1002/gepi.1017

Shivapurkar N., 1999, Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas, Cancer Res., 59, 3576

Dallol A., 2002, SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers, Cancer Res., 62, 5874

10.1016/S0165-4608(01)00475-7

10.1038/sj.onc.1202739

10.1158/1541-7786.MCR-05-0128

10.1002/gcc.20142

10.1002/ijc.11460

10.1002/1097-0215(20000520)89:3<305::AID-IJC15>3.0.CO;2-8

Dellas A., 2002, DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer, Clin. Cancer Res., 8, 1210

10.1111/j.1349-7006.1997.tb00315.x

10.1046/j.1359-4117.2002.01001.x

10.1038/sj.bjc.6695007

Nessling M., 2005, Candidate genes in breast cancer revealed by microarray-based comparative genomic hybridization of archived tissue, Cancer Res., 65, 439, 10.1158/0008-5472.439.65.2

10.1002/(SICI)1097-0215(20000515)86:4<494::AID-IJC8>3.0.CO;2-O

10.1002/(SICI)1098-2264(199903)24:3<255::AID-GCC11>3.0.CO;2-2

10.1038/sj.bjc.6690234

Bieche I., 1998, Deletion mapping in breast tumor cell lines points to two distinct tumor-suppressor genes in the 1p32-pter region, one of deleted regions (1p36.2) being located within the consensus region of LOH in neuroblastoma, Oncol. Rep., 5, 267

10.1016/S0165-4608(01)00473-3

10.1159/000015508

10.1002/gcc.2870100303